Although the increase in PON3 protein expression in the arteries of PAD patients is quantitatively small, it needs to be taken into account that PON3 is about 100 times more potent per mg of protein than PON1, in protecting LDL against lipid peroxidation [36]. Here, PON3 is linked to peripheral arterial disease.